March 25, 2015 – The amount of money that drug companies spent on direct-to-consumer advertising rose from $3.8 billion in 2013 to $4.5 billion in 2014, a potential signal of both a recovering economy and industry’s desire to speak more directly to the patients who are gaining more control of their own healthcare. According to […]
Read more